Published in Surgery Litigation and Law Weekly, February 16th, 2007
Study 1: Data detailed in "High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells" have been presented. "Increase in plasma low density lipoprotein (LDL) levels and/or decrease in high density lipoprotein (HDL) levels are major risk factors for the development of atherosclerosis. An oxidative modification of LDL represents a key process in atherogenesis," investigators in Rome, Italy report.
"It is well known that the LDL/HDL ratio is more important...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly